Alimemazine Hemitartrate Working Standard (Secondary Reference Standard)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

4330-99-8Alimemazine Hemitartrate Working Standard (Secondary Reference Standard)

● Under Development

Catalogue No.:VE0027632
CAS No.:4330-99-8
Mol. Formula:C20H25N2O3S
Mol. Weight:373.53 g/mol

Additional information on CAS 4330-99-8

Parent drug

Alimemazine / Alimemazine Hemitartrate

IUPAC Name

(2RS)-N,N,2-Trimethyl-3-(10H-phenothiazin-10-yl)propan-1-amine hemi[(2R,3R)-2,3-dihydroxybutanedioate]

Smiles

CN(C[C@](C)([H])CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)C.[H][C@](O)(C(O)=O)[C@@]([H])(O)C(O)=O

InChI

InChI=1S/C18H22N2S.C4H6O6/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)21-18-11-7-5-9-16(18)20;5-1(3(7)8)2(6)4(9)10/h4-11,14H,12-13H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t14-;/m1./s1

Description

Alimemazine Hemitartrate Working Standard (Secondary Reference Standard), CAS 4330-99-8, is supplied for research and analytical method development as a controlled secondary reference material. Optimized for use in calibration, method robustness testing and system suitability assessments, this working standard supports quantitative assay development and comparative analytical workflows. The material is intended solely for research and analytical method development and is not certified for use as a primary reference standard for GMP QC batch release or regulatory stability studies. Provided with clear labeling and traceable lot identification, it integrates into laboratory workflows requiring a reproducible secondary comparator for chromatography and spectroscopic method evaluation.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url